[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370658-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370658-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","structure-based-identification-of-potent-fibroblast-growth-factor-receptor-4-fgfr4-inhibitors-as-potential-therapeutics-for-hepatocellular-carcinoma","Structure-based identification of potent fibroblast growth factor receptor 4 (FGFR4) inhibitors as potential therapeutics for hepatocellular carcinoma","","Fibroblast growth factor receptor 4 (FGFR4) is central to cell growth, differentiation, and tissue repair, and its increased expression is observed across multiple cancers, making it a relevant drug target. A structure-based virtual screening campaign was used to identify FGFR4 inhibitors, followed by PAINS filtering and ADME/T property evaluation to obtain two candidates. Quantum mechanical HOMO-LUMO analyses and molecular dynamics at the FGFR4 ATP-binding site supported stability and low reactivity, while MM/PBSA predicted favorable binding free energies. In vitro HepG2 results showed growth inhibition with IC50 values of 47.42 ± 12.93 mM and 77.83 ± 19.17 mM, indicating potential for hepatocellular carcinoma therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/structure-based-identification-of-potent-fibroblast-growth-factor-receptor-4-fgfr4-inhibitors-as-potential-therapeutics-for-hepatocellular-carcinoma/370658/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/structure-based-identification-of-potent-fibroblast-growth-factor-receptor-4-fgfr4-inhibitors-as-potential-therapeutics-for-hepatocellular-carcinoma/370658.png","ImageObject",300,407,{"name":42,"@type":43},"Bintang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main approach used to find FGFR4 inhibitors?","Question",{"text":63,"@type":64},"The study used structure-based virtual screening to identify potential FGFR4 inhibitors, followed by filtering based on PAINS and ADME/T properties.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which computational methods supported the drug-candidate assessment?",{"text":68,"@type":64},"Quantum mechanical HOMO-LUMO calculations assessed electronic features, molecular dynamics confirmed stability at the FGFR4 ATP-binding site, and MM/PBSA estimated binding free energy.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence was reported for the identified compounds?",{"text":72,"@type":64},"In vitro assays showed that MFCD00832235 and MFCD00204244 inhibited HepG2 cell growth, with reported IC50 values of 47.42 ± 12.93 mM and 77.83 ± 19.17 mM, respectively.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370658,1790270772,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Submitted 15 October 2024 Accepted 25 February 2025 Published 18 June 2025  \nCorresponding authors Zhen Fu, [414271691@qq.com](414271691@qq.com)  \nQifa Ye, [yqf_china@163.com](yqf_china@163.com)[ ](yqf_china@163.com)Academic editor Vladimir Uversky  \nAdditional Information and Declarations can be found on page 21  \nDOI 10.7717/peerj.19183  \n Copyright 2025 Fan et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nOPEN ACCESS  \nStructure-based identification of potent fibroblast growth factor receptor  \n4 (FGFR4) inhibitors as potential therapeutics for hepatocellular carcinoma  \nLin Fan1 , Hui Xie1 , Weiyu Wang1 , Guizhu Peng1 , Zhen Fu1 and Qifa Ye1 ,2  \n1 Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, Hubei, China  \n2 The 3rd Xiangya Hospital of Central South University, NHC Key Laboratory of Translational Research on Transplantation Medicine, Changsha, China  \nABSTRACT  \nFibroblast growth factor receptor 4 (FGFR4), a member of the fibroblast growth factor receptor family, plays a crucial role in cell growth, differentiation, and tissue repair. Increased FGFR4 expression has been detected in various cancers, including lung, liver, kidney and pancreatic cancer, making it a potential drug target. In this study, we conducted a structure-based virtual screening campaign to identify potential FGFR4 inhibitors. The retained compounds were further filtered based on pan assay interference compounds (PAINS) and absorption, distribution, metabolism, excretion, and toxicity (ADME/T) properties, leading to the identification of two promising candidates: MFCD00832235 and MFCD00204244 . Quantum mechanical (QM) calculations revealed a large Highest Occupied Molecular Orbital (HOMO) and the Lowest Unoccupied Molecular Orbital (LUMO) (HUMO-LUMO) gaps for both compounds, indicating high dynamic stability and low chemical reactivity. Moreover, the stability of MFCD00832235 and MFCD00204244 at the adenosine triphosphate (ATP)-binding site of FGFR4 was confirmed through molecular dynamics (MD) simulations. The molecular mechanics Poisson-Boltzmann surface area (MM/PBSA) approach predicted favorable binding free energy values for both compounds with the target protein. In vitro assay revealed that MFCD00832235 and MFCD00204244 inhibited the growth of HepG2 cells with IC 50 values of 47.42 􀀆 12.93 mM and 77.83 􀀆 19.17 mM, respectively. Overall, this study suggested that MFCD00832235 and MFCD00204244 were potential FGFR4 inhibitors and may serve as start points for developing novel modulators of FGFR4 for cancer treatment, particularly hepatocellular carcinoma.  \nSubjects Bioinformatics, Computational Biology, Computational Science  \nKeywords Fibroblast growth factor receptor 4 (FGFR4), Hepatocellular carcinoma, Virtual screening, MD simulation, QM calculations, ADMET prediction  \nHow to cite this article Fan L, Xie H, Wang W, Peng G, Fu Z, Ye Q. 2025. Structure-based identification of potent fibroblast growth factor receptor 4 (FGFR4) inhibitors as potential therapeutics for hepatocellular carcinoma. PeerJ 13:e19183 [http://doi.org/10.7717/peerj.19183](http://doi.org/10.7717/peerj.19183)  \nINTRODUCTION  \nFibroblast growth factor receptor 4 (FGFR4), a member of the fibroblast growth factor receptor family, is crucial for regulating cell growth, differentiation, and tissue repair (Haugsten et al., 2010) . The fgfr4 gene, located on human chromosome 5q35.1, spans approximately 11.3 kb and consists of 18 exons ( Vainikka et al., 1992) . FGFR4 is essential for epithelial-mesenchymal interactions, which are crucial for organ development and tissue regeneration (Peláez-García et al., 2013) . By regulating these interactions, FGFR4 helps maintain the structural and functional integrity of tissues (Khosravi et al., 2021) . It is expres","cbCaibH54tuY3Htn","https://ap.wps.com/l/cbCaibH54tuY3Htn","pdf",7687412,23,"English","# Abstract\n# Introduction","[{\"question\":\"What was the main approach used to find FGFR4 inhibitors?\",\"answer\":\"The study used structure-based virtual screening to identify potential FGFR4 inhibitors, followed by filtering based on PAINS and ADME/T properties.\"},{\"question\":\"Which computational methods supported the drug-candidate assessment?\",\"answer\":\"Quantum mechanical HOMO-LUMO calculations assessed electronic features, molecular dynamics confirmed stability at the FGFR4 ATP-binding site, and MM/PBSA estimated binding free energy.\"},{\"question\":\"What experimental evidence was reported for the identified compounds?\",\"answer\":\"In vitro assays showed that MFCD00832235 and MFCD00204244 inhibited HepG2 cell growth, with reported IC50 values of 47.42 ± 12.93 mM and 77.83 ± 19.17 mM, respectively.\"}]","Structure-based identification of potent fibroblast growth factor receptor 4 (FGFR4) inhibitors as potential therapeutics for hepatocellular carcinoma | PDF",1790189676,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c67d7cc9cda665a5ab5d9cb58633a2e0.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd154d8e4701d95669d9ad64f696b611.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6498c1e70fbdf222bf4175c71321c87.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb1110659b6b64602303c3ba22854a08.webp",980,1268]